Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study
Artificial Cells, Nanomedicine, and Biotechnology · Available online 22 Jun 2026 · In press · DOI 10.1080/21691401.2026.2678704
Free full text
Authors (5)
Wafa Ali Batarfi, Mohd Heikal Mohd Yunus, Adila A. Hamid, Manira Maarof, Rizal Abdul Rani
Abstract
Osteoarthritis (OA) presents a significant therapeutic challenge, necessitating innovative biomaterial strategies to reduce chronic inflammation and promote cartilage regeneration. This study developed a hybrid gelatine (GE)/polyvinyl alcohol (PVA) hydrogel crosslinked with genipin (GNP) to effectively deliver Hydroxytyrosol (HT). A 6% GE was incorporated with 3% and 5% PVA concentrations, followed by 0.1% (w/v) GNP. The physicochemical and biocompatibility properties were further evaluated. Physicochemical analysis identified the GPVA5%-GNP formulation as optimal, featuring an interconnected porous structure, optimal swelling ratio (640.43 ± 22.28%), improved hydrophilicity (44.50 ± 1.81°), controlled biodegradation, and enhanced compressive strength (96.88 ± 0.72%). Chemical tests confirmed thermal and structural stability, while biocompatibility assays showed over 95% cell viability. The therapeutic potential was evaluated using an IL-1β-induced inflammatory model in human chondrocytes. MTT assays revealed that HT at 12.5, 25, and 50 μM restored metabolic activity in a dose-dependent manner over 14 days, outperforming the 9 μM Glucosamine Sulphate positive control. The 50 μM HT dose yielded the best metabolic recovery, supported by Live/Dead imaging that showed increased viable cell density from Day 1 to Day 7. Overall, the GPVA5%-GNP hydrogel loaded with 50 μM HT offers a robust protective environment that reduces catabolic stress and promotes cell proliferation, making it a promising localized therapy for cartilage regeneration in OA.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Batarfi, W., Yunus, M., Hamid, A., et al. (2026). Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study. Artificial Cells, Nanomedicine, and Biotechnology. https://doi.org/10.1080/21691401.2026.2678704
Related articles
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Antimicrobial properties and bioactivity of zirconia-based biocomposites · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Human tendon stem/progenitor cell-derived extracellular vesicle production promoted by dynamic culture · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Identification of mitophagy-related biomarkers in human rheumatoid arthritis using machine learning models · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Multi-omics analysis of the potential association between ageing and rheumatoid arthritis and screening of potential therapeutic targets · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Exosome-mediated perturbation of the immune-bone metabolism axis: a mechanistic investigation into bone loss in a simulated microgravity environment · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Engineering nanobodies for drug delivery systems in Alzheimer’s disease · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal